References
- Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2002; 101: 1827–32.
- Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol 2002; 118: 548–57.
- Harris EN, Pierangeli SS. Revisiting the anticardiolipin test and its standardization. Lupus 2002; 11: 269–75.
- Merrill JT. Which antiphospholipid antibody tests are most useful? Rheum Dis Clin North Am 2001; 27: 525–49.
- Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752–63.
- Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphos-pholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309–11.
- Wilson WA. Classification criteria for antiphospholipid syndrome. Rheum Dis Clin North Am 2001; 27: 499–505.
- Robert JM, Macara LM, Chalmers EA, Smith GC. Inter-assay variation in antiphospholipid antibody testing. BJOG 2002; 109: 348–9.
- Tincani A, Allegri F, Sanmarco M, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphos-pholipid Forum. Thromb Haemost 2001; 86: 575–83.
- Fontaine M, Homburger HA, Nichols WL. Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies. Thromb Haemost 2001; 86: 1123–4.
- Favaloro EJ, Silvestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology 1999; 31: 142–7.
- Reber G, Arvieux J, Comby E, et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hemostase et la Thrombose). Thromb Haemost 1995; 73: 444–52.
- Coulam CB, McIntyre JA, Wagenknecht D, Rote N. Interlaboratory inconsistencies in detection of anticardiolipin antibodies. Lancet 1990; 335: 865.
- Greaves M, Cohen H, MacHin Si, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109: 704–15.
- Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019–27.
- Finazzi G. The Italian Registry of Antiphospholipid Antibodies. Haematologica 1997; 82: 101–5.
- Pierangeli SS, Harris EN. Advances in antiphospholipid antibody testing. Clin Appl Immunol Rev 2000; 1: 59–72.
- Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002; 126: 1424–9.
- Wong RCW, Gillis D, Adelstein S, et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology 2004; 36: 63–8.